Citation:
Kesselheim AS, Gagne JJ. Introduction to a supplement on innovative approaches to studying health outcomes in rare diseases. J Gen Intern Med. 2014;29 Suppl 3 :S709-11.
Joshua Gagne
Associate Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Department of Epidemiology, Harvard T.H. Chan School of Public Health
Contact
-
The latest @ASAPprogram lit scan features work from @Rishidesai11 @robertwplatt @KB_Filion @darrentoh_epi @AndersHuitfeldt Link: t.co/wtbeLZMNyM #RxEpi #epitwitter
-
Learn about @PCORnetwork from @texhern and @khaynes001 on the next @ISPE_Exchange webinar. Anyone can register for free: t.co/vWWDID3Der #RxEpi #epitwitter #realworlddata t.co/vLdIqzTRSQ
-
@RachBarenie 31 points for Kombiglyze plus another 9 for XR. That’s currently 2nd place for one word names and 2nd place overall counting the XR.
